Ocuphire Pharma Inc.

05/09/2024 | Press release | Distributed by Public on 06/09/2024 07:46

UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia